Applications published 10 October 2007

Reduction of hair growth with survivin inhibitors
The Gillette Company 1841401*

Process for preparing hydrocolloids
Lubrizol Advanced Materials 1841402*

Cosmetic patch for skin treatment
Younger Skin 1841403*

Skin-condition improving compsn comprising vaccinium ulignosum extract and method for preparation thereof
Chung, Se Young 1841404*

Cosmetic or dermopharmaceutical compsn comprising an euglena extract
Sderma 1841405*

Methods and formulations
SmithKline Beecham 1841406*

Medical devices containing crazed polymeric release regions for drug delivery
Boston Scientific Scimed 1841407*

Delivery of bio-available compounds with anhydrous topical preparations
International Flora Technologies 1841408*

Dosage form for treating gastrointestinal disorders
Pozen 1841409*

Hydrophilic beads for use in topical formulations
International Flora Technologies 1841410*

Sustained release pharmaceutical formulations comprising ranolazine
CV Therapeutics 1841411*

• Controlled long acting release pharmaceutical preparation for use in the oral cavity
Calcident Active 1841412*

• Direct compression formulation and process
Novartis, Novartis-Pharma 1841413*

• Rosiglitazone and metformin formulations
Alpharma 1841414*

• Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
Sirtris Pharmaceuticals 1841415*

• Topical pharmaceutical compsns containing an antiacne compound and antibiotic compound
Glenmark Pharmaceuticals 1841416*

• SPM 927 for add-on therapy of schizophrenia
Schwarz Pharma 1841417*

• Glycine reuptake inhibitors for treating drugs and alcohol dependence
NV Organon 1841418*

• Cathepsin K inhibitors and obesity
Merck Frosst Canada 1841419*

• Treatment of drug-resistant proliferative disorders
Temple University of the Commonwealth System of Higher Education 1841420*

• The use of a lignan for the manufacture of a compsn for preventing or alleviating of symptoms relating to estrogen deficiency
Hormos Medical 1841421*

• Methods of use of dual PPAR agonist compounds and drug delivery devices containing such compounds
Novartis; Novartis-Pharma 1841422*

• Use of 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3 hydroxy-2-amino propionic acid amides and related compounds as analgesics
Allergan 1841423*

• Synthesis of aryl pyrrolidones
IRM 1841424*

• Phenyl-substituted pyrrolidones
IRM 1841425*

• Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of Alzheimer's disease
Merck 1841426*

• Compsns and therapeutic methods utilising a combination of 5-HT1F inhibitor and an NSAID
Pozen 1841427*

• Novel quinolinum salts and derivatives
Immusol 1841428*

• Solid forms of a chemokine receptor antagonist and methods of use thereof
Millennium Pharmaceuticals 1841429*

• Substituted pyridazinyl- and pyrimidinyl-quinolin-4-ylamine analogues
Neurogen 1841430*

• Compounds and compsns as protein kinase inhibitors
IRM 1841431*

• Compsns for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
Venus Remedies 1841432*

• Method and compsn for treating central nervous system disorders
Sucampo 1841433*

• Combination therapy for treating heart disease
Gupta, Ajay 1841434*

• Substance mixture
Pregenzer, Bruno; Konzett, Alfred; Neher, Andreas; Gottardi, Waldemar; Nagl, Markus 1841435*

• Compounds and methods for regulating triglyceride levels
Medicure International 1841436*

• 9A-carbamoyl and thiocarbamoyl azalides with antimalarial activity
GlaxoSmithKline istrazivacki centar Zagreb 1841437*

• Methods for the treatment of lysosomal storage disorders
Stemcells California 1841438*

• Compsns comprising extracts from sanguinaria or macleaya
Indena 1841439*

• Pharmaceutical, therapeutic, and dietary compsns derived from lagerstroemia speciosa L. plant
Renaissance Herbs 1841440*

• Herbal preparation for joints
Vita Green Health Products 1841441*

• Treatment for autoimmune and inflammatory conditions
Northern Sydney and Central Coast Area Health Service 1841442*

• Method and system for treating heart failure
Heart Failure Technologies 1841443*

• Formulations of peptides for periodontal and dental treatments
Alcologix 1841444*

• Therapeutic nutrient compsns or combinations and methods of their use
Critical Care Connections 1841445*

• Peptides and compounds that bind to the IL-5 receptor
Affymax 1841446*

• Use of soluble CD164 variants in inflammatory and/or autoimmune disorders
Laboratoires Serono 1841447*

• Pharmaceutical compsns and methods for restoring beta-cell mass and function
Diakine Therapeutics 1841448*

• Methods and compsns related to modulating the extracellular stem cell environment
The Massachusetts Institute of Technology 1841449*

• Method for producing a vaccine for the treatment of cancer
Avax Technologies 1841450*

• Peptides for delivery of mucosal vaccines
University of Maryland; Istituto Superiore di Sanita 1841451*

• Single domain antibodies against TNFR1 and methods of use therefor
Domantis 1841452*

• Treatment of pre-eclampsia in pregnant women using targeted apheresis
Smith, Henry J 1841453*

• Treatment method
Genetech 1841454*

• Humanised anti-amyloid antibody
Amgen 1841455*

• Stabilised liquid polypeptide formulations
Wyeth 1841456*

• Targeted apheresis for the treatment of rheumatoid arthritis
Smith, Henry J; Smith, James R 1841457*

• Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
Discovery Laboratories 1841458*

• Use of a dihydroimidazopyrazine derivatives for treating or preventing pain
Societe de Conseils de Recherches et d'Applications Scientifiques (SCRAS) 1841459*

• Therapeutic formulations for the treatment of beta-amyloid related diseases
Neurochem (International) 1841460*

• Injectable agent for the targeted treatment of retinal ganglion cells
Eberhard-Karls-Universitaet 1841461*

• Growth factor therapy mobilisation of stem cells into the peripheral blood
Franco, Wayne 1841462*

• Methods and compsns for treating, inhibiting and reversing disorders of the intervertebral disc
Rush University Medical Centre; AnGes 1841463*

• RNAI modulation of the NOGO-L or NOGO-R gene and uses thereof
Alnylam Pharmaceuticals 1841464*

• Stilbene derivatives and their use for binding and imaging amyloid plaques
The Trustees of the University of Pennsylvania 1841465*

• Agents for therapy efficacy monitoring and deep tissue imaging
Vanderbilt University 1841466*

• Combination cancer therapy with anti-PSMA antibodies
Cytogen 1841467*

• Laser activated nanothermolysis of cells
Oraevsky, Alexander; Lapotko, Dimitri 1841468*

• Device for sterilising with gaseous plasma formed from a mixture of nitrogen and hydrogen
Societe pour la Conception des Applications des Techniques Electroniques 1841469*